H
HXNet
Request Full Data Access to the Medutest database of peptide tests.
Products examined
| Product | Rating | Samples | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| GHK-Cu | C | 10 | 6.8 | 4.7 | 10.0 | 17 Nov 2025 |
| Tesamorelin | D | 11 | 6.3 | 3.5 | 8.0 | 24 Jul 2025 |
| Cagrilintide | E | 10 | 6.2 | 2.8 | 8.3 | 17 Nov 2025 |
| Retatrutide | E | 33 | 6.5 | 0.0 | 9.7 | 11 Aug 2025 |
| Tirzepatide | E | 27 | 6.7 | 2.3 | 10.0 | 9 Jun 2025 |
| 5-amino-1MQ Oral | C | 8 | 7.0 | 4.8 | 9.6 | 23 May 2026 |
| AICAR | C | 6 | 7.0 | 5.9 | 8.8 | 19 Jan 2026 |
| ARA-290 | C | 4 | 5.7 | 3.4 | 7.4 | 20 May 2026 |
| Benzaldehyde CAS 100-52-7 | C | 9 | 7.2 | 3.6 | 9.7 | 17 May 2026 |
| Blend 300 (TRA/Mast P/Test P) | C | 4 | 6.3 | 4.6 | 7.6 | 23 May 2026 |
| Boldenone Cypionate | C | 4 | 6.8 | 4.3 | 8.7 | 19 Jan 2026 |
| Botulinum toxin | C | 6 | 6.3 | 4.9 | 8.2 | 21 May 2026 |
| BPC157 5mg + TB500 5mg Blend | C | 2 | 4.8 | 3.4 | 6.2 | 23 May 2026 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | C | 7 | 6.4 | 4.6 | 9.8 | 23 May 2026 |
| Clomid | C | 2 | 4.3 | 3.8 | 4.9 | 21 May 2026 |
| DHB (1-Test Cyp) | X | 1 | 6.4 | 6.4 | 6.4 | 25 Apr 2025 |
| Dihexa | C | 3 | 5.4 | 3.8 | 6.6 | 20 May 2026 |
| GHRP-6 Acetate | C | 4 | 7.6 | 5.0 | 9.0 | 24 May 2026 |
| HMG | C | 7 | 7.0 | 5.7 | 8.7 | 24 May 2026 |
| Hyaluronic acid | C | 7 | 6.7 | 5.8 | 7.8 | 24 May 2026 |
| IGF-1 LR3 | C | 3 | 6.6 | 6.2 | 7.1 | 17 May 2026 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | C | 2 | 6.4 | 6.3 | 6.5 | 21 May 2026 |
| MT-1 | C | 6 | 6.9 | 3.9 | 8.7 | 21 May 2026 |
| P21 | C | 6 | 6.6 | 4.5 | 7.7 | 21 May 2026 |
| Pinealon | C | 5 | 6.6 | 4.9 | 8.3 | 21 May 2026 |
| Primobolan Oral (Methenolone Acetate) | C | 6 | 6.1 | 3.2 | 7.6 | 23 May 2026 |
| RAD140 | C | 8 | 6.8 | 4.9 | 9.4 | 19 Jan 2026 |
| Retatrutide Raw | C | 8 | 6.3 | 5.1 | 10.0 | 26 Jan 2026 |
| Sildenafil (Viagra) | C | 2 | 5.2 | 4.3 | 6.1 | 24 May 2026 |
| Super Shred | C | 2 | 5.8 | 5.1 | 6.4 | 19 Jan 2026 |
| Test Suspension | C | 9 | 6.6 | 4.6 | 9.5 | 26 Jan 2026 |
| Vilon | C | 8 | 5.5 | 4.7 | 6.8 | 24 May 2026 |
| Winstrol (Stanozolol) | C | 5 | 7.0 | 5.8 | 8.8 | 24 May 2026 |
The certificates
| Date | Product | Score | Declared | Measured | Deviation | Purity | Laboratory |
|---|---|---|---|---|---|---|---|
| 25 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 7.0 | 30mg | 30.5mg | +1.7% | 98.94% | Lab A |
| 24 May 2026 | Blend 300 (TRA/Mast P/Test P) | 8.8 | 250mg/ml | 272.0mg/ml | +8.8% | 97.69% | Lab F |
| 24 May 2026 | Boldenone Cypionate | 7.3 | 200mg/ml | 182.0mg/ml | -9.0% | 95.98% | Lab A |
| 24 May 2026 | HMG | 8.0 | 5mg | 6.1mg | +22.0% | 95.91% | Lab F |
| 24 May 2026 | P21 | 6.2 | 2mg | 2.0mg | +2.2% | 96.13% | Lab F |
| 24 May 2026 | P21 | 6.4 | 30mg | 34.8mg | +16.0% | 99.39% | Lab G |
| 24 May 2026 | Vilon | 6.5 | 30mg | 34.3mg | +14.2% | 99.18% | Lab F |
| 24 May 2026 | Retatrutide | 7.5 | 15mg | 14.4mg | -4.0% | 99.70% | No Label / Silver Crimp / Red Cap |
| 24 May 2026 | Tesamorelin | 4.2 | 5mg | 3.6mg | -28.0% | 99.60% | No Label / Silver Crimp / Orange Cap |
| 24 May 2026 | Tirzepatide | 8.0 | 20mg | 20.8mg | +4.0% | 99.90% | White Label / Silver Crimp / Red Cap |
| 24 May 2026 | Tesamorelin | 7.3 | 10mg | 9.7mg | -3.0% | 99.60% | No Label / Silver Crimp / White Cap |
| 24 May 2026 | Tirzepatide | 6.1 | 10mg | 10.2mg | +2.0% | 99.06% | No Label / Silver Crimp / Orange Cap |
| 24 May 2026 | 5-amino-1MQ Oral | 7.6 | 50mg | 44.0mg | -11.9% | 98.29% | Lab D |
| 24 May 2026 | AICAR | 7.9 | 5mg | 4.3mg | -14.1% | 97.22% | Lab G |
| 24 May 2026 | Benzaldehyde CAS 100-52-7 | 6.3 | 5g | 4.7g | -6.5% | 95.43% | Lab D |
| 24 May 2026 | BPC157 5mg + TB500 5mg Blend | 4.9 | 2mg | 2.4mg | +19.2% | 96.91% | Lab D |
| 24 May 2026 | Pinealon | 4.9 | 2mg | 1.9mg | -5.3% | 96.32% | Lab E |
| 24 May 2026 | RAD140 | 6.0 | 100mg | 110.8mg | +10.8% | 97.96% | Lab B |
| 24 May 2026 | Retatrutide Raw | 9.0 | 1g | 1.2g | +24.0% | 95.42% | Lab A |
| 24 May 2026 | Retatrutide | 6.5 | 20mg | 22mg | +10.0% | 99.90% | No Label / Silver Crimp / Yellow Cap |
| 24 May 2026 | 5-amino-1MQ Oral | 8.2 | 50mg | 47.1mg | -5.9% | 96.92% | Lab E |
| 24 May 2026 | Blend 300 (TRA/Mast P/Test P) | 5.1 | 100mg/ml | 119.9mg/ml | +19.9% | 95.54% | Lab B |
| 24 May 2026 | IGF-1 LR3 | 5.6 | 30mg | 30.7mg | +2.3% | 95.13% | Lab G |
| 24 May 2026 | Test Suspension | 8.7 | 250mg/ml | 270.8mg/ml | +8.3% | 95.93% | Lab A |
| 24 May 2026 | Winstrol (Stanozolol) | 8.8 | 100mg | 87.3mg | -12.7% | 96.21% | Lab B |
| 24 May 2026 | AICAR | 8.2 | 30mg | 27.7mg | -7.8% | 97.40% | Lab C |
| 24 May 2026 | Botulinum toxin | 4.9 | 15mg | 17.0mg | +13.6% | 97.10% | Lab C |
| 24 May 2026 | RAD140 | 6.8 | 25mg | 25.5mg | +1.9% | 99.10% | Lab A |
| 24 May 2026 | Test Suspension | 8.4 | 100mg/ml | 118.4mg/ml | +18.4% | 99.54% | Lab D |
| 24 May 2026 | Blend 300 (TRA/Mast P/Test P) | 4.0 | 200mg/ml | 203.1mg/ml | +1.6% | 95.34% | Lab F |
| 24 May 2026 | Clomid | 4.0 | 20mg | 18.1mg | -9.5% | 99.54% | Lab D |
| 24 May 2026 | GHRP-6 Acetate | 8.0 | 30mg | 26.6mg | -11.4% | 98.17% | Lab F |
| 23 May 2026 | Hyaluronic acid | 5.7 | 2mg | 2.1mg | +4.9% | 96.24% | Lab A |
| 23 May 2026 | Retatrutide Raw | 5.8 | 1g | 1.1g | +9.5% | 98.78% | Lab E |
| 23 May 2026 | Winstrol (Stanozolol) | 8.3 | 25mg | 21.6mg | -13.6% | 95.63% | Lab A |
| 23 May 2026 | Cagrilintide | 4.4 | 10mg | 9.31mg | -6.9% | 96.68% | No Label / Silver Crimp / Black Cap |
| 23 May 2026 | Boldenone Cypionate | 6.9 | 300mg/ml | 368.7mg/ml | +22.9% | 97.14% | Lab E |
| 23 May 2026 | Botulinum toxin | 6.0 | 30mg | 35.7mg | +19.1% | 96.79% | Lab A |
| 23 May 2026 | GHRP-6 Acetate | 9.5 | 2mg | 1.8mg | -8.1% | 97.40% | Lab D |
| 23 May 2026 | Test Suspension | 6.5 | 100mg/ml | 107.1mg/ml | +7.1% | 99.42% | Lab B |
| 23 May 2026 | Vilon | 6.2 | 30mg | 37.0mg | +23.4% | 95.72% | Lab G |
| 23 May 2026 | Winstrol (Stanozolol) | 6.8 | 50mg | 56.2mg | +12.5% | 96.64% | Lab B |
| 21 May 2026 | 5-amino-1MQ Oral | 7.3 | 50mg | 55.6mg | +11.3% | 95.38% | Lab A |
| 21 May 2026 | Benzaldehyde CAS 100-52-7 | 5.9 | 1g | 1.0g | -1.6% | 97.71% | Lab G |
| 21 May 2026 | Dihexa | 4.5 | 50mg | 62.5mg | +24.9% | 96.49% | Lab G |
| 21 May 2026 | Hyaluronic acid | 5.9 | 5mg | 4.8mg | -3.5% | 98.59% | Lab A |
| 21 May 2026 | AICAR | 6.1 | 20mg | 23.4mg | +17.0% | 96.96% | Lab D |
| 21 May 2026 | Hyaluronic acid | 6.8 | 20mg | 24.6mg | +23.2% | 95.31% | Lab B |
| 21 May 2026 | Primobolan Oral (Methenolone Acetate) | 4.7 | 50mg | 60.9mg | +21.8% | 96.94% | Lab F |
| 21 May 2026 | Test Suspension | 4.0 | 250mg/ml | 298.2mg/ml | +19.3% | 98.31% | Lab D |
| 20 May 2026 | Benzaldehyde CAS 100-52-7 | 5.3 | 100g | 103.9g | +3.9% | 97.85% | Lab D |
| 20 May 2026 | Botulinum toxin | 5.5 | 5mg | 5.7mg | +13.6% | 98.87% | Lab B |
| 20 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 5.8 | 2mg | 2.1mg | +6.4% | 95.80% | Lab G |
| 20 May 2026 | MT-1 | 10.0 | 50mg | 53.9mg | +7.9% | 99.40% | Lab E |
| 20 May 2026 | MT-1 | 6.7 | 50mg | 61.5mg | +23.0% | 98.61% | Lab B |
| 19 May 2026 | 5-amino-1MQ Oral | 6.6 | 10mg | 9.4mg | -5.8% | 98.98% | Lab G |
| 19 May 2026 | Benzaldehyde CAS 100-52-7 | 5.7 | 10g | 9.1g | -8.9% | 98.03% | Lab E |
| 19 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 7.2 | 2mg | 2.0mg | +1.3% | 98.24% | Lab G |
| 19 May 2026 | Clomid | 4.1 | 10mg | 11.5mg | +15.5% | 96.11% | Lab G |
| 19 May 2026 | Dihexa | 5.3 | 100mg | 99.7mg | -0.3% | 97.76% | Lab A |
| 19 May 2026 | GHRP-6 Acetate | 8.8 | 15mg | 17.8mg | +19.0% | 99.46% | Lab F |
| 19 May 2026 | Hyaluronic acid | 6.5 | 20mg | 21.4mg | +6.8% | 99.93% | Lab D |
| 17 May 2026 | ARA-290 | 6.1 | 50mg | 60.4mg | +20.8% | 97.68% | Lab B |
| 17 May 2026 | HMG | 7.2 | 5mg | 6.2mg | +24.8% | 99.53% | Lab B |
| 17 May 2026 | Winstrol (Stanozolol) | 8.2 | 100mg | 91.6mg | -8.4% | 98.34% | Lab A |
| 29 Jan 2026 | Benzaldehyde CAS 100-52-7 | 5.7 | 500g | 587.5g | +17.5% | 98.69% | Lab B |
| 29 Jan 2026 | Benzaldehyde CAS 100-52-7 | 9.4 | 500g | 606.7g | +21.3% | 98.36% | Lab A |
| 29 Jan 2026 | HMG | 7.8 | 30mg | 35.7mg | +19.2% | 98.46% | Lab D |
| 29 Jan 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 6.0 | 2mg | 2.0mg | -0.1% | 95.80% | Lab D |
| 29 Jan 2026 | Test Suspension | 4.9 | 100mg/ml | 109.8mg/ml | +9.8% | 95.11% | Lab F |
| 26 Jan 2026 | HMG | 5.3 | 20mg | 22.3mg | +11.5% | 97.83% | Lab D |
| 26 Jan 2026 | Hyaluronic acid | 7.3 | 20mg | 23.9mg | +19.3% | 98.07% | Lab F |
| 26 Jan 2026 | MT-1 | 7.2 | 5mg | 4.3mg | -14.5% | 96.91% | Lab E |
| 26 Jan 2026 | Retatrutide Raw | 5.5 | 500g | 465.1g | -7.0% | 97.98% | Lab B |
| 26 Jan 2026 | Super Shred | 6.4 | 100mg/ml | 114.7mg/ml | +14.7% | 99.42% | Lab F |
| 26 Jan 2026 | Vilon | 6.7 | 50mg | 57.8mg | +15.5% | 98.16% | Lab A |
| 19 Jan 2026 | Botulinum toxin | 6.4 | 15mg | 14.2mg | -5.2% | 97.51% | Lab G |
| 19 Jan 2026 | DHB (1-Test Cyp) | 6.5 | 250mg/ml | 291.1mg/ml | +16.4% | 98.88% | Lab G |
| 19 Jan 2026 | Test Suspension | 7.2 | 100mg/ml | 97.9mg/ml | -2.1% | 95.60% | Lab A |
| 19 Jan 2026 | Vilon | 4.1 | 50mg | 56.4mg | +12.8% | 98.63% | Lab B |
| 9 Jan 2026 | 5-amino-1MQ Oral | 8.3 | 20mg | 23.9mg | +19.4% | 99.96% | Lab C |
| 9 Jan 2026 | ARA-290 | 4.3 | 5mg | 4.9mg | -1.7% | 95.98% | Lab D |
| 9 Jan 2026 | Boldenone Cypionate | 6.5 | 250mg/ml | 250.0mg/ml | +0.0% | 96.93% | Lab D |
| 9 Jan 2026 | Botulinum toxin | 6.7 | 5mg | 5.8mg | +15.1% | 98.78% | Lab D |
| 9 Jan 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 4.7 | 30mg | 27.6mg | -8.1% | 98.28% | Lab F |
| 9 Jan 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 6.2 | 10mg | 11.5mg | +15.2% | 95.84% | Lab D |
| 9 Jan 2026 | Pinealon | 7.2 | 5mg | 5.7mg | +14.8% | 95.97% | Lab G |
| 9 Jan 2026 | Test Suspension | 7.5 | 250mg/ml | 231.6mg/ml | -7.4% | 97.56% | Lab A |
| 7 Jan 2026 | ARA-290 | 5.3 | 20mg | 23.9mg | +19.4% | 95.70% | Lab F |
| 7 Jan 2026 | MT-1 | 6.7 | 20mg | 20.4mg | +2.1% | 99.37% | Lab A |
| 7 Jan 2026 | Primobolan Oral (Methenolone Acetate) | 6.0 | 25mg | 25.1mg | +0.4% | 96.76% | Lab G |
| 7 Jan 2026 | Primobolan Oral (Methenolone Acetate) | 7.2 | 20mg | 18.8mg | -6.0% | 97.91% | Lab D |
| 7 Jan 2026 | RAD140 | 8.1 | 25mg | 26.9mg | +7.4% | 99.53% | Lab C |
| 7 Jan 2026 | Vilon | 4.3 | 2mg | 1.9mg | -7.5% | 97.07% | Lab E |
| 7 Jan 2026 | Vilon | 5.6 | 30mg | 37.3mg | +24.2% | 98.17% | Lab D |
| 6 Jan 2026 | GHRP-6 Acetate | 7.7 | 50mg | 51.7mg | +3.3% | 95.63% | Lab C |
| 6 Jan 2026 | Pinealon | 7.7 | 20mg | 19.0mg | -5.1% | 95.80% | Lab E |
| 6 Jan 2026 | Primobolan Oral (Methenolone Acetate) | 4.4 | 50mg | 59.8mg | +19.6% | 97.94% | Lab A |
| 6 Jan 2026 | RAD140 | 7.3 | 25mg | 29.1mg | +16.2% | 97.26% | Lab A |
| 6 Jan 2026 | Sildenafil (Viagra) | 4.8 | 20mg | 24.5mg | +22.4% | 95.59% | Lab A |
| 29 Dec 2025 | 5-amino-1MQ Oral | 7.4 | 10mg | 10.3mg | +3.0% | 97.43% | Lab E |
| 29 Dec 2025 | Benzaldehyde CAS 100-52-7 | 9.3 | 10g | 9.4g | -5.7% | 96.84% | Lab G |
| 29 Dec 2025 | BPC157 5mg + TB500 5mg Blend | 6.3 | 15mg | 13.1mg | -12.6% | 97.38% | Lab G |
| 29 Dec 2025 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 7.8 | 5mg | 6.2mg | +24.5% | 96.68% | Lab A |
| 29 Dec 2025 | RAD140 | 7.2 | 25mg | 28.8mg | +15.0% | 96.96% | Lab E |
| 29 Dec 2025 | Sildenafil (Viagra) | 4.0 | 25mg | 26.3mg | +5.0% | 96.71% | Lab G |
| 12 Dec 2025 | Blend 300 (TRA/Mast P/Test P) | 5.2 | 300mg/ml | 288.3mg/ml | -3.9% | 98.82% | Lab E |
| 12 Dec 2025 | Retatrutide Raw | 7.1 | 100g | 108.7g | +8.7% | 96.90% | Lab B |
| 12 Dec 2025 | Winstrol (Stanozolol) | 4.7 | 20mg | 21.0mg | +5.0% | 99.77% | Lab A |
| 5 Dec 2025 | AICAR | 5.5 | 15mg | 17.8mg | +18.4% | 97.49% | Lab B |
| 5 Dec 2025 | AICAR | 8.9 | 30mg | 26.0mg | -13.2% | 99.23% | Lab E |
| 5 Dec 2025 | Benzaldehyde CAS 100-52-7 | 6.3 | 1g | 0.9g | -6.0% | 95.38% | Lab B |
| 5 Dec 2025 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 5.0 | 20mg | 23.4mg | +17.0% | 96.42% | Lab F |
| 5 Dec 2025 | Test Suspension | 4.9 | 100mg/ml | 88.8mg/ml | -11.2% | 99.87% | Lab A |
| 23 Nov 2025 | Botulinum toxin | 8.2 | 5mg | 5.6mg | +11.4% | 99.52% | Lab C |
| 23 Nov 2025 | HMG | 7.4 | 2mg | 1.8mg | -10.5% | 98.54% | Lab F |
| 23 Nov 2025 | IGF-1 LR3 | 6.4 | 5mg | 6.1mg | +22.0% | 98.24% | Lab A |
| 23 Nov 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 6.3 | 10mg | 12.4mg | +24.1% | 96.32% | Lab D |
| 23 Nov 2025 | RAD140 | 5.6 | 10mg | 10.3mg | +3.1% | 95.26% | Lab G |
| 23 Nov 2025 | Retatrutide Raw | 6.0 | 500g | 515.8g | +3.2% | 98.85% | Lab D |
| 17 Nov 2025 | Dihexa | 5.5 | 25mg | 24.9mg | -0.3% | 97.92% | Lab E |
| 17 Nov 2025 | MT-1 | 7.0 | 50mg | 62.0mg | +24.0% | 98.31% | Lab E |
| 17 Nov 2025 | RAD140 | 7.3 | 10mg | 11.4mg | +14.4% | 99.96% | Lab E |
| 14 Nov 2025 | 5-amino-1MQ Oral | 8.3 | 25mg | 31.1mg | +24.5% | 95.47% | Lab B |
| 14 Nov 2025 | Retatrutide Raw | 8.7 | 100g | 123.7g | +23.7% | 99.21% | Lab F |
| 5 Nov 2025 | AICAR | 6.7 | 5mg | 4.5mg | -10.7% | 99.35% | Lab F |
| 5 Nov 2025 | HMG | 6.8 | 5mg | 5.9mg | +17.4% | 95.48% | Lab D |
| 5 Nov 2025 | Hyaluronic acid | 6.7 | 50mg | 55.7mg | +11.5% | 99.15% | Lab B |
| 5 Nov 2025 | P21 | 8.0 | 50mg | 48.8mg | -2.5% | 97.48% | Lab G |
| 5 Nov 2025 | Primobolan Oral (Methenolone Acetate) | 5.3 | 50mg | 53.8mg | +7.7% | 98.47% | Lab F |
| 5 Nov 2025 | Test Suspension | 6.0 | 200mg/ml | 238.5mg/ml | +19.3% | 98.84% | Lab D |
| 5 Nov 2025 | Vilon | 5.3 | 5mg | 4.6mg | -7.4% | 97.83% | Lab D |
| 4 Nov 2025 | ARA-290 | 5.7 | 15mg | 13.5mg | -10.1% | 97.28% | Lab C |
| 4 Nov 2025 | HMG | 8.0 | 50mg | 61.9mg | +23.9% | 97.37% | Lab D |
| 4 Nov 2025 | P21 | 6.7 | 5mg | 5.9mg | +17.4% | 96.43% | Lab A |
| 4 Nov 2025 | Pinealon | 6.6 | 50mg | 50.4mg | +0.8% | 98.78% | Lab E |
| 4 Nov 2025 | Super Shred | 6.3 | 100mg/ml | 114.8mg/ml | +14.8% | 98.27% | Lab F |
| 17 Oct 2025 | 5-amino-1MQ Oral | 8.0 | 100mg | 111.8mg | +11.8% | 99.50% | Lab B |
| 17 Oct 2025 | IGF-1 LR3 | 8.0 | 30mg | 29.8mg | -0.7% | 95.35% | Lab F |
| 17 Oct 2025 | MT-1 | 6.3 | 30mg | 25.7mg | -14.4% | 98.16% | Lab D |
| 9 Oct 2025 | Boldenone Cypionate | 5.3 | 200mg/ml | 174.3mg/ml | -12.9% | 95.03% | Lab A |
| 9 Oct 2025 | Retatrutide Raw | 7.4 | 100g | 90.2g | -9.8% | 98.83% | Lab C |
| 3 Oct 2025 | Benzaldehyde CAS 100-52-7 | 8.6 | 100g | 123.5g | +23.5% | 99.09% | Lab B |
| 3 Oct 2025 | Hyaluronic acid | 7.2 | 10mg | 11.8mg | +18.2% | 95.79% | Lab F |
| 3 Oct 2025 | P21 | 7.8 | 50mg | 51.5mg | +3.0% | 97.99% | Lab D |
| 3 Oct 2025 | P21 | 5.6 | 50mg | 50.9mg | +1.7% | 98.19% | Lab F |
| 3 Oct 2025 | Pinealon | 5.4 | 2mg | 2.3mg | +14.2% | 98.69% | Lab C |
| 3 Oct 2025 | Primobolan Oral (Methenolone Acetate) | 7.1 | 20mg | 19.5mg | -2.5% | 97.16% | Lab B |
| 3 Oct 2025 | RAD140 | 6.3 | 20mg | 18.1mg | -9.5% | 99.96% | Lab B |
| 3 Oct 2025 | Retatrutide Raw | 4.1 | 100g | 85.7g | -14.3% | 95.89% | Lab F |
| 3 Oct 2025 | Vilon | 7.1 | 20mg | 18.4mg | -7.9% | 95.45% | Lab C |